T-Knife GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2018-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.t-knife.com
A Phase 1/ 2, First-in-Human, Open-Label, Accelerated-Titration, Two-Part Clinical Trial of TK-8001 in Patients With HLA-A*02:01 Genotype and Advanced-Stage/ Metastatic MAGE-A1+ Solid Tumors
Phase 1
Terminated
- Conditions
- Advanced Solid Tumors
- Interventions
- Biological: Autologous CD8+ T-cells, transduced with MAGE-A1 directed TCR
- First Posted Date
- 2022-06-24
- Last Posted Date
- 2024-02-07
- Lead Sponsor
- T-knife GmbH
- Target Recruit Count
- 23
- Registration Number
- NCT05430555
- Locations
- 🇧🇪
Universite Libre de Bruxelles (ULB) - Institut Jules Bordet Anderlecht, Brussel, Belgium
🇧🇪Centre Hospitalier Universitaire (CHU) de Liège, Liège, Belgium
🇧🇪Universite Catholique de Louvain (UCL) - Cliniques Universitaires Saint-Luc - Institut Roi Albert II, Brussels, Belgium
© Copyright 2025. All Rights Reserved by MedPath